We reviewed available evidence for cardiovascular effects of n-3 polyunsaturated fatty acid
(PUFA) consumption, focusing on long chain (seafood) n-3 PUFA, including their principal …

The microvascular endothelial cell monolayer localized at the critical interface between the
blood and vessel wall has the vital functions of regulating tissue fluid balance and supplying …

In various embodiments, the present invention provides methods of reducing the risk of a
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …

US8298554B2 - Stable pharmaceutical composition and methods of using same - Google
Patents US8298554B2 - Stable pharmaceutical composition and methods of using same …

US9814733B2 - Compositions comprising EPA and obeticholic acid and methods of use
thereof - Google Patents US9814733B2 - Compositions comprising EPA and obeticholic …

Intercellular communication in many organs is maintained via intercellular gap junction
channels composed of connexins, a large protein family with a number of isoforms. This gap …

US8455472B2 - Compositions and methods for lowering triglycerides without raising LDL-C
levels in a subject on concomitant statin therapy - Google Patents US8455472B2 …

In various embodiments, the present invention provides methods of treating and/or
preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy …

The present invention relates to, inter alia, pharmaceutical compositions comprising EPA
and one or more cardiovascular agents, and to therapeutic methods for treating various …

We have previously reported that the n-3 polyunsaturated fatty acid eicosapentaenoic acid
(EPA) inhibited the abnormal gap junctional intercellular communication (GJIC) induced by …